Anixa Biosciences (ANIX) Cash from Operations (2010 - 2026)
Anixa Biosciences' Cash from Operations came in at -$1.77 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), compared with -$1.51 million a year earlier.
Powered by 
Analysis
Anixa Biosciences (ANIX) Cash from Operations (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jul 31, 2026, Anixa Biosciences reported Cash from Operations of -$6.04 million; for FY2025 (ended Oct 31, 2025), it came in at -$7.17 million.
- Going back by fiscal year, Cash from Operations was -$7.34 million in FY2024, -$6.21 million in FY2023, -$6.49 million in FY2022 and -$4.94 million in FY2021.
- The fiscal Q3 2026 figure represents the lowest quarterly Cash from Operations since fiscal Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.58 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.00 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.57 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 835.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.13 Bn |
| 10 | Anixa Biosciences | 101.33 Mn | 100.06 Mn | - | -1.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -1.77 Mn |
| Oct 31, 2025 | -1.26 Mn |
| Jul 31, 2025 | -1.51 Mn |
| Apr 30, 2025 | -1.50 Mn |
| Jan 31, 2025 | -2.90 Mn |
| Oct 31, 2024 | -927,000.00 |
| Jul 31, 2024 | -2.64 Mn |
| Apr 30, 2024 | -1.46 Mn |
| Jan 31, 2024 | -2.31 Mn |
| Oct 31, 2023 | -1.97 Mn |
| Jul 31, 2023 | -1.45 Mn |
| Apr 30, 2023 | -807,000.00 |
| Jan 31, 2023 | -1.99 Mn |
| Oct 31, 2022 | -1.59 Mn |
| Jul 31, 2022 | -1.40 Mn |
| Apr 30, 2022 | -2.31 Mn |
| Jan 31, 2022 | -1.20 Mn |
| Oct 31, 2021 | -1.05 Mn |
| Jul 31, 2021 | -1.48 Mn |
| Apr 30, 2021 | -1.24 Mn |
API Access
Anixa Biosciences Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();